Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas

被引:35
作者
Kokkola, A
Monni, O
Puolakkainen, P
Nordling, S
Haapiainen, R
Kivilaakso, E
Knuutila, S
机构
[1] Univ Helsinki, Cent Hosp, Med Genet Lab, FIN-00029 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Surg 2, FIN-00029 Helsinki, Finland
[3] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland
[4] Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland
关键词
D O I
10.1016/S0165-4608(98)00092-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our aim was to investigate the presence of DNA copy number changes in gastric adenomas and to identify the changes that may play a role in gastric carcinogenesis. DNA copy number changes in 16 patients with gastric adenoma and in 22 tumors from patients with intestinal type gastric carcinomas were studied by using comparative,genomic hybridization. DNA copy number changes were found in 44% of the adenoma cases and in 86% of the intestinal type gastric carcinomas. On average, gains were more common than losses (0.9 vs. 0.5 in adenomas and 4.1 vs. 1.8 in carcinomas). In adenomas, the most common gains involved chromosome 8 in 3 cases, and gain of chromosome 7 and 20q was detected in 2 cases. The most frequent losses were observed at 5q (three times). Only adenomas with severe dysplasia showed high-level amplifications that were detected at chromosome 13, 17cen-q22, and 20q12-ter. In gastric cancer, the most common gains were detected at 20q (55%), 17q12-q21 (41%), and 8q (41%), and the most common losses were detected at 18q (43%) and 4q (32%). High-level amplifications were observed at 20q (3 tumors), 17cen-q21 (3 tumors), 2p (1 tumor), and 18q (1 tumor). These findings suggest that the progression of dysplasia is associated with higher levels of DIVA copy number increase (e.g., the gains at 17q and 20q), which were typically observed in the intestinal type gastric cancer. Furthermore, the results support the hypothesis that adenoma precedes cancer. (C) Elsevier Science Inc., 1998.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 40 条
[1]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[2]   EXPRESSION OF P53 IN EARLY (T1) GASTRIC-CARCINOMA AND PRECANCEROUS ADJACENT MUCOSA [J].
BRITO, MJ ;
WILLIAMS, GT ;
THOMPSON, H ;
FILIPE, MI .
GUT, 1994, 35 (12) :1697-1700
[3]  
CORREA P, 1988, CANCER RES, V48, P3554
[4]   CHRONOLOGY OF P53 PROTEIN ACCUMULATION IN GASTRIC CARCINOGENESIS [J].
CRAANEN, ME ;
BLOK, P ;
DEKKER, W ;
OFFERHAUS, GJA ;
TYTGAT, GNJ .
GUT, 1995, 36 (06) :848-852
[5]  
DIGREGORIO C, 1993, AM J GASTROENTEROL, V88, P1714
[6]  
ElRifai W, 1996, CANCER RES, V56, P3230
[7]   EARLY AND ADVANCED GASTRIC-CANCER IN THE FOLLOW-UP OF MODERATE AND SEVERE GASTRIC DYSPLASIA PATIENTS - A PROSPECTIVE-STUDY [J].
FARINATI, F ;
RUGGE, M ;
DIMARIO, F ;
VALIANTE, F ;
BAFFA, R .
ENDOSCOPY, 1993, 25 (04) :261-264
[8]   CLINICAL-SIGNIFICANCE OF GASTRIC DYSPLASIA - A MULTICENTER FOLLOW-UP-STUDY [J].
FERTITTA, AM ;
COMIN, U ;
TERRUZZI, V ;
MINOLI, G ;
ZAMBELLI, A ;
CANNATELLI, G ;
BODINI, P ;
BERTOLI, G ;
NEGRI, R ;
BRUNATI, S ;
FIOCCA, R ;
TURPINI, F ;
PRADA, A ;
CERETTI, E ;
GULLOTTA, R ;
CORNAGGIA, M .
ENDOSCOPY, 1993, 25 (04) :265-268
[9]   INCREASED EXPRESSION OF THE RETINOBLASTOMA GENE IN HUMAN COLORECTAL CARCINOMAS RELATIVE TO NORMAL COLONIC MUCOSA [J].
GOPE, R ;
CHRISTENSEN, MA ;
THORSON, A ;
LYNCH, HT ;
SMYRK, T ;
HODGSON, C ;
WILDRICK, DM ;
GOPE, ML ;
BOMAN, BM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (04) :310-314
[10]  
HATTORI T, 1986, CANCER, V57, P1528, DOI 10.1002/1097-0142(19860415)57:8<1528::AID-CNCR2820570815>3.0.CO